Registered non-profits and charities can now apply for a grant to get free yearly access (valued at $1800) to the powerful Legalese Decoder Business plan. We understand that legal complexities can be ...
deCODE genetics has announced its acquisition of privately-held Icelandic cancer research firm Urdur, Verdandi Skuld (UVS). The acquisition enables deCODE to broaden and enhance its cancer program by ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Repertoire Immune Medicines, a clinical-stage biotech company decoding the immune synapse to create novel immune therapies for cancer, immune disorders, infectious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback